Neurogenic Bowel

Loss or absence of normal intestinal function due to nerve damage or birth defects. It is characterized by the inability to control the elimination of stool from the body.

Drugs by status

Phase 4 trials (2)

glycerin
human milk

Phase 3 trials (2)

glycopyrronium
neostigmine

Organizations

Organization Involved with Phase 4 Indications (4)

Thomas Jefferson University
University of Florida
University of Western Ontario
Government of Canada

Organization Involved with Phase 1 Indications (1)

Department of Veteran Affairs